Sectoral Asset Management Inc Novo Cure LTD Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $8,466 - $17,821	150 Added 9.38%	1,750 $105,000
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $13,597 - $17,914	200 Added 14.29%	1,600 $122,000
Q2 2022 Aug 15, 2022	BUY	$56.6 - $89.9 $79,240 - $125,860	1,400 New	1,400 $97,000
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $4.86 Million - $8.13 Million	-41,800 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $5.45 Million - $9.43 Million	41,800 New	41,800 $9.27 Million
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $888,165 - $1.7 Million	-15,300 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $875,160 - $1.14 Million	15,300 New	15,300 $907,000

266

76.7M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.54B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.